Detalles de la búsqueda
1.
Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany.
Eur J Clin Pharmacol
; 80(6): 931-940, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472389
2.
Electronic health record characterization and outcomes of heart failure with preserved ejection fraction.
Am Heart J
; 263: 1-14, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116604
3.
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.
Europace
; 18(8): 1150-7, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26830891
4.
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
Europace
; 18(2): 184-90, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26487668
5.
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany.
Am J Cardiovasc Drugs
; 24(3): 409-418, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573461
6.
Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.
Sci Rep
; 14(1): 9095, 2024 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643208
7.
Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study.
Patient Prefer Adherence
; 17: 1181-1196, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163154
8.
Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes.
J Prim Care Community Health
; 13: 21501319211063726, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35068244
9.
Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization.
J Cardiovasc Med (Hagerstown)
; 22(1): 45-52, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32941326
10.
Glomerular filtration rate change and outcomes in type 2 diabetes.
Am J Manag Care
; 27(8 Suppl): S160-S167, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019358
11.
Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database.
Mayo Clin Proc
; 96(4): 975-986, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722396
12.
Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile.
Drugs Real World Outcomes
; 7(3): 221-227, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533499
13.
Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure.
Am Health Drug Benefits
; 13(4): 166-174, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33343816
14.
Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes.
JAMA Netw Open
; 3(1): e1918962, 2020 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922560
15.
Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
J Med Econ
; 23(5): 513-520, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31928390
16.
Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model.
Clin Epidemiol
; 12: 607-616, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606986
17.
Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials.
Clin Pharmacol Ther
; 105(5): 1156-1163, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30107034
18.
Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure.
Circ Cardiovasc Qual Outcomes
; 11(12): e004700, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30562067
19.
[Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain]. / Coste-efectividad de la adición de acarbosa al tratamiento de pacientes con diabetes tipo 2 en España.
Gac Sanit
; 21(2): 97-104; discussion 105, 2007.
Artículo
en Español
| MEDLINE | ID: mdl-17419924
20.
Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting.
Curr Med Res Opin
; 22(7): 1415-24, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16834840